2,4-difluoro-N-(2-methoxy-5-(4-morpholinothieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl)benzenesulfonamide

ID: ALA4745332

PubChem CID: 162371682

Max Phase: Preclinical

Molecular Formula: C22H19F2N5O4S2

Molecular Weight: 519.56

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ncc(-c2cc3c(N4CCOCC4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F

Standard InChI:  InChI=1S/C22H19F2N5O4S2/c1-32-21-17(28-35(30,31)19-3-2-14(23)9-16(19)24)8-13(11-25-21)18-10-15-20(26-12-27-22(15)34-18)29-4-6-33-7-5-29/h2-3,8-12,28H,4-7H2,1H3

Standard InChI Key:  HFDGVAZLABKEEV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   15.6463   -4.3336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6505   -5.1508    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.3561   -4.7386    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7058   -3.3306    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7047   -4.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4788   -4.6582    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4109   -2.9218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1196   -3.3270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1198   -4.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9028   -4.4044    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.3865   -3.7382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9024   -3.0725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2004   -3.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6087   -4.4457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4251   -4.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8343   -3.7374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4211   -3.0275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6060   -3.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6515   -3.7360    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0589   -3.0276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8336   -5.1536    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0593   -5.8614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6479   -6.5678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0557   -7.2751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8737   -7.2757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2823   -6.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8721   -5.8587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8307   -6.5661    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.2832   -7.9829    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.4108   -2.1080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1191   -1.6985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1187   -0.8849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4115   -0.4747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7032   -0.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7021   -1.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 11 13  1  0
 16 19  1  0
 19 20  1  0
 15 21  1  0
 21  2  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 23 28  1  0
 25 29  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
  7 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745332

    ---

Associated Targets(Human)

NCI-H292 (733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGC-27 (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CD Tclin PI3-kinase p110-delta subunit (6699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BGC-823 (3035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SGC-7901 (2773 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKN-45 (2102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-16 (476 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1437 (152 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.56Molecular Weight (Monoisotopic): 519.0847AlogP: 3.68#Rotatable Bonds: 6
Polar Surface Area: 106.54Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.56CX Basic pKa: 3.79CX LogP: 3.41CX LogD: 2.77
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.41Np Likeness Score: -2.35

References

1. Sun Y,Fu R,Lin S,Zhang J,Ji M,Zhang Y,Wu D,Zhang K,Tian H,Zhang M,Sheng L,Li Y,Jin J,Chen X,Xu H.  (2021)  Discovery of new thieno[2,3-d]pyrimidine and thiazolo[5,4-d]pyrimidine derivatives as orally active phosphoinositide 3-kinase inhibitors.,  29  [PMID:33285407] [10.1016/j.bmc.2020.115890]

Source